Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Quanome Technologies, Inc. (QNME)

Quanome to take ~5% stake in QAI Labs in exchange for 6.5 million new shares

Mixed Impact 4 of 5 m&a

Quanome agreed on November 4, 2026 to acquire 31,579 newly issued shares of QAI Labs, an early-stage, pre-commercial life sciences company, in exchange for 6,541,236 new Quanome common shares, about 19% of its shares outstanding before the issuance. The parties assigned the consideration shares an aggregate value of $5.0 million, which implies an equity valuation of about $100 million for QAI Labs, and the deal is subject to closing conditions. For shareholders, the deal brings new strategic exposure but also meaningful dilution.

Key points

  • Quanome issues 6,541,236 new common shares, about 19% of shares outstanding before issuance and about 15.97% after.
  • Quanome receives 31,579 QAI Labs shares, an interest of about 5% immediately after issuance.
  • Aggregate negotiated transaction value is $5.0 million; implied QAI Labs equity valuation is about $100 million.
  • The agreement can be terminated if closing has not occurred by December 31, 2026, unless the parties agree otherwise.

The filing

CompanyQuanome Technologies, Inc. (QNME)
Form8-K, current report
Filed with the SECNov 9, 2026, 8:01 AM ET
Accession number0001213900-26-117226

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:25 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.